In models of gout, crystal-induced IL-1β production has been shown to be affected by Cathepsin B inhibitors that prevent lysosomal instability [38], and crystal-induced IL-1β production can be blocked by colchicine, a prophylactic drug for FMF patients [39]. This evidence concerns the gene IL1B and gout.